Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Celsius Holdings Faces Stock Price Decline and Investor Confidence Challenge

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Beverages Industry Markets and money
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On January 19, 2024, Celsius Holdings witnessed a significant decline in its stock price following a downgrade by B of A Securities. The renowned securities firm revised its rating from Buy to Neutral and set a price target of $65. As a result, the stock experienced an 11% drop during morning trading, settling at $53.30.

Despite the downward trend, it is worth noting that the analyst’s price target still indicates a considerable potential for growth. However, the decision to downgrade the stock has undoubtedly impacted its market value. B of A Securities made this call based on their assessment of various factors, including the company’s future prospects for expansion and potential growth in international markets.

Overall, the downgrade by B of A Securities has significantly impacted Celsius Holdings’ stock price on January 19, 2024. The company now faces the challenge of regaining investor confidence and demonstrating its ability to overcome the concerns raised by the analyst’s outlook.

Celsius Holdings Inc. Stock (CELH) Drops 10.54% on January 19, 2024: What Investors Need to Know

CELH, the stock of Celsius Holdings Inc., experienced a significant drop in its price on January 19, 2024. According to data sourced from CNN Money, the stock opened at $57.26, which was $2.34 lower than its previous closing price. The price drop of CELH shares on that day amounted to $6.28, representing a decline of 10.54%. Despite this decline, it is important to note that CELH is currently trading in the middle of its 52-week range. However, it is worth mentioning that trading in the middle of the range does not necessarily guarantee future stability. Additionally, the stock is trading above its 200-day simple moving average, indicating that the stock has been performing well in the long term. Investors should carefully consider these factors before making any decisions regarding CELH. It is crucial for investors to conduct thorough research, analyze market trends, and consult with financial advisors to gain a comprehensive understanding of CELH’s prospects and potential risks. Stock performance can be influenced by various factors, including company-specific news, industry trends, and overall market conditions. Investors should exercise caution and make informed decisions based on their individual investment goals and risk tolerance.

Celsius Holdings (CELH) Stock Performance on January 19, 2024: Analyzing Revenue, Net Income, and EPS

CELH Stock Performance on January 19, 2024: A Closer Look at the Numbers

On January 19, 2024, Celsius Holdings (CELH) stock experienced significant fluctuations in its performance. By analyzing the financial data sourced from CNN Money, we can gain insights into the company’s total revenue, net income, and earnings per share (EPS) for the past year and the third quarter.

Total Revenue:
CELH’s total revenue for the past year stood at $653.60 million, representing a remarkable 107.97% increase compared to the previous year. Furthermore, CELH’s total revenue for the third quarter amounted to $384.76 million, reflecting an 18.07% increase since the previous quarter.

Net Income:
CELH reported a loss of -$187.28 million over the past year. However, net income increased by 4856.64% since last year. In the third quarter, CELH’s net income rebounded strongly, reaching $83.95 million, reflecting a substantial 62.98% increase compared to the previous quarter.

Earnings per Share (EPS):
CELH reported an EPS of -$0.88 over the past year, representing a significant decrease of 5283.43% compared to the previous year. However, in the third quarter, CELH’s EPS rebounded strongly, reaching $0.30, reflecting a substantial 72.35% increase compared to the previous quarter.

Conclusion:
CELH’s stock performance on January 19, 2024, showcased remarkable growth in total revenue, net income, and EPS. Investors should closely monitor CELH’s financial performance, as the company demonstrates its potential for sustained growth and increased shareholder value.

Tags: CELH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Processa Pharmaceuticals Inc Experiences Surge in Stock Price Due to Expansion of Next Generation Capecitabine in Breast Cancer Treatment

CTVA stock news

Lam Research Incs Unique PE Ratio and Considerations for Investment Decisions

Technology Robotics Stock Market Today

The Future of the Global IoT Market Projected Growth and Opportunities

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com